Hormone therapy may reduce COVID-19 risk in women

14 May 2020


Menopausal women receiving hormone replacement therapy may have a reduced risk of contracting and falling seriously ill from COVID-19.

Telegraph


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story